Lyell Immunopharma Company Profile, Contacts & Intelligence

Lyell Immunopharma Overview

Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.

Headquarters

South San Francisco, California, United States

Website

lyell.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Lyell Immunopharma Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Lyell Immunopharma People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Lyell Immunopharma Workforce Composition

Seniority breakdown across 34 visible profiles.

Lyell Immunopharma Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Lyell Immunopharma

Explore companies in related markets and compare their industry and employee estimates.